Morning Hypertension and Preminent Therapy Study
NCT00795847
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
216
Enrollment
OTHER
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
Preminent (losartan/hydrochlorothiazide combination drug)
Sponsor
Kurume University